Literature DB >> 33652875

Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods.

Manoochehr Khazaee1, Emerson Christie2, Weixiao Cheng1, Mandy Michalsen3, Jennifer Field2, Carla Ng1,4.   

Abstract

The biological impacts of per- and polyfluorinated alkyl substances (PFAS) are linked to their protein interactions. Existing research has largely focused on serum albumin and liver fatty acid binding protein, and binding affinities determined with a variety of methods show high variability. Moreover, few data exist for short-chain PFAS, though their prevalence in the environment is increasing. We used molecular dynamics (MD) to screen PFAS binding to liver and intestinal fatty acid binding proteins (L- and I-FABPs) and peroxisome proliferator activated nuclear receptors (PPAR-α, -δ and -γ) with six perfluoroalkyl carboxylates (PFCAs) and three perfluoroalkyl sulfonates (PFSAs). Equilibrium dissociation constants, KDs, were experimentally determined via equilibrium dialysis (EqD) with liquid chromatography tandem mass spectrometry for protein-PFAS pairs. A comparison was made between KDs derived from EqD, both here and in literature, and other in vitro approaches (e.g., fluorescence) from literature. EqD indicated strong binding between PPAR-δ and perfluorobutanoate (0.044 ± 0.013 µM) and perfluorohexane sulfonate (0.035 ± 0.0020 µM), and between PPAR-α and perfluorohexanoate (0.097 ± 0.070 µM). Unlike binding affinities for L-FABP, which increase with chain length, KDs for PPARs showed little chain length dependence by either MD simulation or EqD. Compared with other in vitro approaches, EqD-based KDs consistently indicated higher affinity across different proteins. This is the first study to report PPARs binding with short-chain PFAS with KDs in the sub-micromolar range.

Entities:  

Keywords:  equilibrium dialysis; equilibrium dissociation constants; fatty acid-binding proteins; per- and polyfluorinated alkyl substances; peroxisome proliferator-activated receptors

Year:  2021        PMID: 33652875      PMCID: PMC7996760          DOI: 10.3390/toxics9030045

Source DB:  PubMed          Journal:  Toxics        ISSN: 2305-6304


  71 in total

1.  Perfluorinated compounds in the vicinity of a fire training area--human biomonitoring among 10 persons drinking water from contaminated private wells in Cologne, Germany.

Authors:  Odulf Weiss; Gerhard A Wiesmüller; Anne Bunte; Thomas Göen; Carsten K Schmidt; Michael Wilhelm; Jürgen Hölzer
Journal:  Int J Hyg Environ Health       Date:  2011-10-15       Impact factor: 5.840

Review 2.  Sources, fate and transport of perfluorocarboxylates.

Authors:  Konstantinos Prevedouros; Ian T Cousins; Robert C Buck; Stephen H Korzeniowski
Journal:  Environ Sci Technol       Date:  2006-01-01       Impact factor: 9.028

Review 3.  Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology.

Authors:  T Lemberger; B Desvergne; W Wahli
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

4.  Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Authors:  Stephanie J Frisbee; Anoop Shankar; Sarah S Knox; Kyle Steenland; David A Savitz; Tony Fletcher; Alan M Ducatman
Journal:  Arch Pediatr Adolesc Med       Date:  2010-09

5.  Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures.

Authors:  Seung-Kyu Kim; Kyu Tae Lee; Chang Seong Kang; Lin Tao; Kurunthachalam Kannan; Kyung-Ryul Kim; Chan-Kook Kim; Jung Suk Lee; Pan Soo Park; Yung Wook Yoo; Jeong Yi Ha; Yong-Seung Shin; Jong-Hyeon Lee
Journal:  Environ Pollut       Date:  2010-10-06       Impact factor: 8.071

6.  In Vitro and In Silico Evaluations of Binding Affinities of Perfluoroalkyl Substances to Baikal Seal and Human Peroxisome Proliferator-Activated Receptor α.

Authors:  Hiroshi Ishibashi; Masashi Hirano; Eun-Young Kim; Hisato Iwata
Journal:  Environ Sci Technol       Date:  2019-01-31       Impact factor: 9.028

Review 7.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

8.  Subsurface transport potential of perfluoroalkyl acids at aqueous film-forming foam (AFFF)-impacted sites.

Authors:  Jennifer L Guelfo; Christopher P Higgins
Journal:  Environ Sci Technol       Date:  2013-04-25       Impact factor: 9.028

9.  Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding.

Authors:  Fernanda A H Batista; Daniela B B Trivella; Amanda Bernardes; Joyce Gratieri; Paulo S L Oliveira; Ana Carolina M Figueira; Paul Webb; Igor Polikarpov
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.752

10.  Avogadro: an advanced semantic chemical editor, visualization, and analysis platform.

Authors:  Marcus D Hanwell; Donald E Curtis; David C Lonie; Tim Vandermeersch; Eva Zurek; Geoffrey R Hutchison
Journal:  J Cheminform       Date:  2012-08-13       Impact factor: 5.514

View more
  3 in total

Review 1.  PFAS and Potential Adverse Effects on Bone and Adipose Tissue Through Interactions With PPARγ.

Authors:  Andrea B Kirk; Stephani Michelsen-Correa; Cliff Rosen; Clyde F Martin; Bruce Blumberg
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 5.051

2.  Early-Life Exposure to Per- and Poly-Fluorinated Alkyl Substances and Growth, Adiposity, and Puberty in Children: A Systematic Review.

Authors:  Yun Jeong Lee; Hae Woon Jung; Hwa Young Kim; Yoon-Jung Choi; Young Ah Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-09       Impact factor: 5.555

Review 3.  Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms.

Authors:  Melvin E Andersen; Bruno Hagenbuch; Udayan Apte; J Christopher Corton; Tony Fletcher; Christopher Lau; William L Roth; Bart Staels; Gloria L Vega; Harvey J Clewell; Matthew P Longnecker
Journal:  Toxicology       Date:  2021-07-08       Impact factor: 4.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.